Express Scripts Holding Co's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Express Scripts Holding Co (ESRX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Express Scripts Holding Co vs Its Competitors
- TTM: Trailing 12-month revenue of 101,353M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is holding steady (+0.9% annualized vs trailing 12 months).
- Peer revenue share: Express Scripts Holding Co accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
ESRX Sales vs. its Competitors, Q1 2018
Express Scripts Holding Co generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Pharmacy Services & Retail Drugstore industry grew revenue 6.7% year over year, combined, vs 3.6% for Express Scripts Holding Co. Express Scripts Holding Co's share of combined industry revenue moved from 6.13% to 5.95%, a loss of 0.18 percentage points.
Express Scripts Holding Co's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Express Scripts Holding Co. | Yes | Yes | Yes | No |
| High-Confidence Competitors (4) | ||||
| Similar Growth & Profitability (8) | 50.00 % (4 of 8) | 62.50 % (5 of 8) | 62.50 % (5 of 8) | 12.50 % (1 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
ESRX Stock Performance relative to its Competitors
ESRX Stock Performance relative to High-Confidence Competitors
ESRX Stock Performance relative to Similar Growth & Profitability Competitors
Express Scripts Holding Co's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| The Cigna Group | Named by the company | 85% |
| Goodrx Holdings Inc | Named by the company | 85% |
| Buckle Inc | Named by the company | 85% |
| Sanofi | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Express Scripts Holding Co's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.